Browsing by Author "Mansilha, A"
Now showing 1 - 7 of 7
Results Per Page
Sort Options
- Aneurisma venoso palmar: caso clínicoPublication . Lopes, JA; Brandão, D; Figueiredo, A; Mansilha, A
- Correcção endovascular de aneurisma da artéria esplénica: caso clínicoPublication . Lopes, JA; Brandão, D; Mansilha, ASplenic artery aneurysms, although they are the most common splanchnic aneurysms, they have a prevalence of only 0,01%. In this context the authors present a case report of a 41 years female patient with a splenic artery aneurysm of 20x29mm, treated by deployment of a covered self-expandable stent (Gore® Viabahn®). It is performed a literature review of the pathology in question, possible complications and made reference to the various treatment options, with particular emphasis on the new endovascular techniques.
- Endovascular Treatment of Symptomatic Renal Artery Aneurysm with Hostile AnatomyPublication . Sousa, J; Mansilha, A
- Endovascular Treatment of Symptomatic Renal Artery Aneurysm with Hostile AnatomyPublication . Sousa, J; Mansilha, A
- Estratégia terapêutica na doença venosa crónicaPublication . Medeiros, J; Mansilha, AChronic venous disease (CVD) is a highly prevalent pathology that compromises patient’s quality of life, and has an important impact socioeconomically. Its treatment passes through the adoption of hygiene-dietetic measures, pharmacological therapy and elastic compression, as well as approaches that are able to ablate venous reflux and hypertension such as mechanical, thermic or chemical ablations. Due to the multiplicity of therapeutic approaches available nowadays, it is important to search for the more effective ones. The objective of this work is to establish a systematic clinical orientation for patients with chronic venous disease, taking into account the CEAP classification, the published results and the recommendations available, in a way to achieve clinical improvement and to answer patient’s expectations. English articles were searched in Medline in concern to the treatment of chronic venous disease. Articles cited by others contained in the initial research were also included. It was possible to understand that chronic venous disease treatment must be individualized and established according to the clinical state. Hygiene-dietetic measures must be adopted by all patients and the different compressions degrees adjusted to the CEAP classification. Pharmacological therapy induces symptomatic relieve and improves complications. All ablation techniques can be performed in an ambulatory setting. Thermal ablation is a promising treatment although there is lack of long term results for recurrence, whereas the chemical ablation, despite being the cheapest, is the mayor cause of pigmentation and recanalization. Mechanical approaches can be performed without general anesthesia and patients are able to return to work the day after the procedure.
- Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug TherapyPublication . Mansilha, A; Sousa, JChronic venous disease (CVD) is a common pathology, with significant physical and psychological impacts for patients and high economic costs for national healthcare systems. Throughout the last decades, several risk factors for this condition have been identified, but only recently, have the roles of inflammation and endothelial dysfunction been properly assessed. Although still incompletely understood, current knowledge of the pathophysiological mechanisms of CVD reveals several potential targets and strategies for therapeutic intervention, some of which are addressable by currently available venoactive drugs. The roles of these drugs in the clinical improvement of venous tone and contractility, reduction of edema and inflammation, as well as in improved microcirculation and venous ulcer healing have been studied extensively, with favorable results reported in the literature. Here, we aim to review these pathophysiological mechanisms and their implications regarding currently available venoactive drug therapies.
- Percutaneous Endovascular Aortic Repair with Local Anesthesia - One Day SurgeryPublication . Sousa, J; Brandão, D; Barreto, P; Ferreira, J; Almeida Lopes, J; Mansilha, ATo evaluate the results of the abdominal aortic aneurism endovascular treatment (EVAR), percutaneously and with local anesthesia, according to the concept of one day surgery. MATERIAL AND METHODS: Unicentric, retrospective analysis of patients with aorto-iliac aneurysmal disease, consecutively treated by EVAR with percutaneous access trough the Preclose technique (pEVAR), according to the outpatient criteria, with one overnight stay in the hospital. The technical success, exclusion of the aneurysmal sac, endoleak, re-intervention and mortality were evaluated. RESULTS: Twenty consecutive patients (all male; mean age 74.65 years) were treated by EVAR with percutaneous access and local anesthesia, from which 95% (19) presented with abdominal aortic aneurysm and 5% (1) common iliac aneurysm. All implants were sucessfully performed, with an initial endoleak rate of 10% (2), determined by one type 1a endoleak successfully corrected intra-operatively and one type 2a endoleak diagnosed in the first imaging control, which sealed spontaneously on the second control. Initial technical success for percutaneous closure was 97.5%, with one case reported of femoral pseudo-aneurism, posteriorly treated by percutaneous thrombin injection. Median length of stay was one day [1-10], with a mean follow-up of 11.4 months [1-36]. Both the re-intervention and mortality rate are 0% for the selected period. CONCLUSION: Our one day surgery model for the outpatient treatment of abdominal aortic aneurysm by the pEVAR technique is innovative, safe and effective, as long as the selection criteria are respected.